Pharmaceutical Crystals
The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutic...
Saved in:
: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (148 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548479304498 |
---|---|
ctrlnum |
(CKB)4100000011302223 (oapen)https://directory.doabooks.org/handle/20.500.12854/56130 (EXLCZ)994100000011302223 |
collection |
bib_alma |
record_format |
marc |
spelling |
Uekusa, Hidehiro auth Pharmaceutical Crystals MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (148 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals. English crystal structure analysis famotidine solution crystallization salt optimization structure determination from powder diffraction data Hirshfeld surface analysis DFT molecular docking study melting diagram dehydration hygroscopicity HBV Benzodioxole pharmaceutical crystals 4-b]indol-4-one pyrimidin-4(3H)-one liquid assisted grinding HOMO-LUMO dissolution cocrystal formation Raman spectroscopy carbamazepine hydrogen bonding 3 ondansetron physicochemical properties solubility succinic acid cocrystal adefovir dipivoxil hepatitis B polymorphs hydrogen-bond-acceptance ability DFT study Nitrofurantoin-4-dimethylaminopyridine (NF-DMAP) salt photostability on-line monitoring 5-dihydro-4H-pyrimido[5 Imidazole Semicarbazone crystal habit Crystal structure solvent-mediated polymorphic transformation ticagrelor hydrate pharmaceutical cocrystal malonic acid 1H-indole reactivity descriptors famoxadone crystal structure dicarboxylic acid hydrogen bond saccharin 3-03928-712-5 Yonemochi, Etsuo auth |
language |
English |
format |
eBook |
author |
Uekusa, Hidehiro |
spellingShingle |
Uekusa, Hidehiro Pharmaceutical Crystals |
author_facet |
Uekusa, Hidehiro Yonemochi, Etsuo |
author_variant |
h u hu |
author2 |
Yonemochi, Etsuo |
author2_variant |
e y ey |
author_sort |
Uekusa, Hidehiro |
title |
Pharmaceutical Crystals |
title_full |
Pharmaceutical Crystals |
title_fullStr |
Pharmaceutical Crystals |
title_full_unstemmed |
Pharmaceutical Crystals |
title_auth |
Pharmaceutical Crystals |
title_new |
Pharmaceutical Crystals |
title_sort |
pharmaceutical crystals |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (148 p.) |
isbn |
3-03928-713-3 3-03928-712-5 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT uekusahidehiro pharmaceuticalcrystals AT yonemochietsuo pharmaceuticalcrystals |
status_str |
n |
ids_txt_mv |
(CKB)4100000011302223 (oapen)https://directory.doabooks.org/handle/20.500.12854/56130 (EXLCZ)994100000011302223 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Pharmaceutical Crystals |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652141132120064 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03991nam-a2200925z--4500</leader><controlfield tag="001">993548479304498</controlfield><controlfield tag="005">20231214132832.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03928-713-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000011302223</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/56130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000011302223</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Uekusa, Hidehiro</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Crystals</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (148 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal structure analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">famotidine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solution crystallization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">salt optimization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">structure determination from powder diffraction data</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hirshfeld surface analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DFT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular docking study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melting diagram</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dehydration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hygroscopicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HBV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Benzodioxole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmaceutical crystals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">4-b]indol-4-one</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pyrimidin-4(3H)-one</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid assisted grinding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HOMO-LUMO</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cocrystal formation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Raman spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbamazepine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bonding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ondansetron</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">physicochemical properties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solubility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">succinic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cocrystal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adefovir dipivoxil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymorphs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen-bond-acceptance ability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DFT study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nitrofurantoin-4-dimethylaminopyridine (NF-DMAP) salt</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">photostability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">on-line monitoring</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">5-dihydro-4H-pyrimido[5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Imidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Semicarbazone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal habit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Crystal structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solvent-mediated polymorphic transformation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ticagrelor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmaceutical cocrystal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malonic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">1H-indole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactivity descriptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">famoxadone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dicarboxylic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bond</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">saccharin</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-712-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yonemochi, Etsuo</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:32:58 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-06-20 22:16:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338866380004498&Force_direct=true</subfield><subfield code="Z">5338866380004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338866380004498</subfield></datafield></record></collection> |